107 related articles for article (PubMed ID: 23131941)
1. Immunohistochemistry: applications to the evaluation of lung and pleural neoplasms: part 2.
Mani H; Zander DS
Chest; 2012 Nov; 142(5):1324-1333. PubMed ID: 23131941
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry: applications to the evaluation of lung and pleural neoplasms: part 1.
Mani H; Zander DS
Chest; 2012 Nov; 142(5):1316-1323. PubMed ID: 23131940
[TBL] [Abstract][Full Text] [Related]
3. [Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study].
Dessy E; Falleni M; Del Curto B; Braidotti P; Pietra GG
Pathologica; 2000 Dec; 92(6):496-502. PubMed ID: 11234300
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry of pulmonary and pleural neoplasia.
Beasley MB
Arch Pathol Lab Med; 2008 Jul; 132(7):1062-72. PubMed ID: 18605762
[TBL] [Abstract][Full Text] [Related]
5. Expression of thrombomodulin, calretinin, cytokeratin 5/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma.
Comin CE; Novelli L; Cavazza A; Rotellini M; Cianchi F; Messerini L
Tumori; 2014; 100(5):559-67. PubMed ID: 25343553
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of membranous staining of mesothelioma.
King JA; Tucker JA
Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemistry of mesotheliomas. Technique and current diagnostic contribution of immunohistochemical markers. General review].
Galateau-Salle F
Arch Anat Cytol Pathol; 1993; 41(5-6):212-22. PubMed ID: 8135582
[TBL] [Abstract][Full Text] [Related]
9. D2-40: a reliable marker in the diagnosis of pleural mesothelioma.
Müller AM; Franke FE; Müller KM
Pathobiology; 2006; 73(1):50-4. PubMed ID: 16785767
[TBL] [Abstract][Full Text] [Related]
10. Utility of immunohistochemistry in the diagnosis of pleuropulmonary and mediastinal cancers: a review and update.
Zhang K; Deng H; Cagle PT
Arch Pathol Lab Med; 2014 Dec; 138(12):1611-28. PubMed ID: 25427041
[TBL] [Abstract][Full Text] [Related]
11. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and histochemical markers of primary lung cancer, lung metastases, and pleural mesotheliomas.
Popper H; Wirnsberger G; Hoefler H; Denk H
Cancer Detect Prev; 1987; 10(3-4):167-74. PubMed ID: 2436780
[TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
[TBL] [Abstract][Full Text] [Related]
14. Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural Neoplasms.
Woo JS; Reddy OL; Koo M; Xiong Y; Li F; Xu H
Arch Pathol Lab Med; 2017 Sep; 141(9):1195-1213. PubMed ID: 28644685
[TBL] [Abstract][Full Text] [Related]
15. Value of D2-40 in the differential diagnosis of pleural neoplasms with emphasis on its positivity in solitary fibrous tumor.
Hu Y; Yang Q; McMahon LA; Wang HL; Xu H
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):411-3. PubMed ID: 20436345
[TBL] [Abstract][Full Text] [Related]
16. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
Ordóñez NG
Mod Pathol; 1998 Oct; 11(10):929-33. PubMed ID: 9796717
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE
Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
[TBL] [Abstract][Full Text] [Related]
18. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
19. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
20. The use of immunohistochemistry in the diagnosis of composite and collision tumors: exemplified by pleural mesothelioma and carcinoid tumor of the lung.
Ordóñez NG
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):421-6. PubMed ID: 22710819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
